CAPTRUST FINANCIAL ADVISORS
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1512024
RALEIGH, NC
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,619,509
+$3,289,148 QoQ
Shares Held
35,471
+10.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#278
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. VRTX ranks #3 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,619,509 | 35,471 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,330,361 | 32,092 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,258,181 | 13,804 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,728,661 | 12,074 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $5,926,502 | 13,312 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $6,559,614 | 13,530 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,851,729 | 12,048 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,701,337 | 14,409 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,609,889 | 14,102 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $6,959,030 | 16,648 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,995,931 | 22,109 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,559,767 | 18,864 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $7,416,151 | 21,074 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $6,473,428 | 20,546 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,629,477 | 19,494 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,651,820 | 19,520 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $5,762,605 | 20,450 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $5,072,734 | 19,438 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,664,245 | 16,686 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,500,464 | 19,298 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,148,049 | 15,613 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,027,174 | 4,780 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $395,396 | 1,673 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,254,745 | 4,611 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $1,150,788 | 3,964 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $408,322 | 1,716 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||